← Leaderboards
Jie Bin Liu
University Of Pittsburgh At Pittsburgh
$161,206
Attributed
$161,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$161,206 · 1
By mechanism
F30$161,206 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Matthew J Sikora$3,621,914
- Michael John Palladino$10,111,937
- Shilpa Sant$3,502,776
- Yi Huang$1,791,828
- George C. Tseng$5,515,023
Others in their field
Other Rising Stars on “Acceleration”
- Angee Greer · Ppd Development Lp$82,531,927
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Nancy Jean Sullivan · Boston University Medical Campus$23,000,000
- Alanna Maguire · Mayo Clinic Rochester$16,353,346
- Michael Hogarth · University Of California, San Diego$15,375,743
Research focus
AccelerationAutomobile DrivingBreastAntibody-Drug ConjugatesCadherinsCell LineCharacteristicsClinically RelevantClinically SignificantClinical ManagementClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCombined Modality TherapyComplementDependenceDrug ResistanceE-CadherinEffective TherapyEngineeringEnvironmentEpidermal Growth Factor ReceptorErbb2 GeneEstrogen Receptor PositiveEvolution
Grant awards (3)
Characterizing and Targeting ERBB2 Mutations in Invasive Lobular Carcinoma$54,538
F30 · FY2025 · CA · contact PI
Characterizing and Targeting ERBB2 Mutations in Invasive Lobular Carcinoma$53,974
F30 · FY2024 · CA · contact PI
Characterizing and Targeting ERBB2 Mutations in Invasive Lobular Carcinoma$52,694
F30 · FY2023 · CA · contact PI